Chimeric crRNA improves CRISPR-Cas12a specificity in the N501Y mutation detection of Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2

Many CRISPR/Cas platforms have been established for the detection of SARS-CoV-2. But the detection platform of the variants of SARS-CoV-2 is scarce because its specificity is very challenging to achieve for those with only one or a few nucleotide(s) differences. Here, we report for the first time that chimeric crRNA could be critical in enhancing the specificity of CRISPR-Cas12a detecting of N501Y, which is shared by Alpha, Beta, Gamma, and Mu variants of SARS-CoV-2 without compromising its sensitivity. This strategy could also be applied to detect other SARS-CoV-2 variants that differ only one or a few nucleotide(s) differences.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:16

Enthalten in:

PloS one - 16(2021), 12 vom: 02., Seite e0261778

Sprache:

Englisch

Beteiligte Personen:

Yang, Jun [VerfasserIn]
Barua, Nilakshi [VerfasserIn]
Rahman, Md Nannur [VerfasserIn]
Lo, Norman [VerfasserIn]
Tsang, Tsz Fung [VerfasserIn]
Yang, Xiao [VerfasserIn]
Chan, Paul K S [VerfasserIn]
Zhang, Li [VerfasserIn]
Ip, Margaret [VerfasserIn]

Links:

Volltext

Themen:

DNA Primers
Journal Article
RNA, Guide, CRISPR-Cas Systems
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 25.01.2022

Date Revised 04.01.2024

published: Electronic-eCollection

Citation Status MEDLINE

doi:

10.1371/journal.pone.0261778

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM334778344